Biotech company Regeneron to buy bankrupt 23andMe for $256M
Ars Technica » Scientific Method 2025-05-19
Summary:
Regeneron will use trove of 23andMe genetic data to develop medical advances.
Link:
https://arstechnica.com/science/2025/05/biotech-company-regeneron-to-buy-bankrupt-23andme-for-256m/From feeds:
Cyberlaw » Ars TechnicaMusic and Digital Media » Ars Technica
Berkeley Law Library -- Reference & Research Services » Ars Technica » Scientific Method